Literature DB >> 26578725

Reply to the letter to the editor 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumor response and tolerance' by Funck-Brentano et al.

E Funck-Brentano1, J C Alvarez2, C Longvert1, E Abe2, A Beauchet3, P Saiag1, C Funck-Brentano4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26578725     DOI： 10.1093/annonc/mdv549

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma.

Authors:  Ashley M Hopkins; Michael J Sorich; Ganessan Kichenadasse; Jim Henry Hughes; John O Miners; Arduino A Mangoni; Andrew Rowland
Journal:  Cancer Chemother Pharmacol       Date:  2019-11-30       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.